Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Rituximab and lenalidomide for the treatment of relapsed ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
0
Authors
Giulio Cassanello
22 more
Giulio Cassanello
•
Esther Drill
20 more
•
Lorenzo Falchi
Published
September 5, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Haematologica
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.3324/haematol.2024.285600
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Haematologica
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.3324/haematol.2024.285600
License
CC-BY-NC
